Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

Clinical trial NCT00240578 · COMPLETED

Trial details

NCT number: NCT00240578
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Non-Hodgkin

Start date: 2003-11-01
Primary completion: 2013-06-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.